Polarean names Charles Osborne as new CFO

Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.

Osborne will replace Polarean's current CFO Bill Patrick, who will stay with the group as financial controller to Polarean Inc, the AIM-listed group's wholly owned subsidiary.

Before his time with Innocrin Pharmaceuticals, a privately held oncology therapeutics business, Osborne was CFO of Scynexis, a publicly traded anti-infective company between 2003 and 2015.

Chief executive Richard Hullihen said: "Chuck's previous capital markets experience coupled with his knowledge of financial operations within the pharmaceutical industry will ensure strong leadership of the company's financial function."

As of 0920 BST, Polarean shares had slipped 2.94% to 16.50p.